For example, the transcription regulator PRMT5 (protein arginine methyltransferase 5) was identified as a potential gene target in combination with gemcitabine for pancreatic ductal adenocarcinoma [129]. The gene discussed is PRMT5; the disease is pancreatic ductal adenocarcinoma.